33
/fr/
AIzaSyAYiBZKx7MnpbEhh9jyipgxe19OcubqV5w
August 1, 2025
10193602
975418
2

8 mars 2024 - Wegovy Approved by The FDA

Description:

The FDA expands the approval of semaglutide (Wegovy) to include heart disease, making it the first weight-loss drug to be approved for reducing the risk of cardiovascular events in adults who have cardiovascular disease and are either obese or overweight.

Ajouté au bande de temps:

Date:

8 mars 2024
Maintenaint
~ Il y a 1 ans et 3 mois